Njei explains the evolving treatment landscape for MASLD and how it impacts the cost-effectiveness of noninvasive tests for screening.
Basile Njei, MD, PhD, MPH
Advertisement
Basile Njei, MD, PhD, MPH, is an assistant professor at Yale School of Medicine.
Articles by Basile Njei, MD, PhD, MPH
Using AI to Improve Risk Stratification, Disease Management in MASLD, With Basile Njei, MD, PhD, MPH
Njei explains the utility of Fibro-GPT for detecting advanced fibrosis and predicting hepatic decompensation in MASLD.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
Navigating Emotional Burden in IBD
2
Obinutuzumab Achieves 95.5% Remission in INS, May Shift Steroid-Sparing Treatment Strategies
3
What Will Precision Dermatology Look Like in Atopic Dermatitis?
4
Why Dermatologists Should Add Serum Tryptase to the Workup for Chronic Itch
5